Business Wire

  1. BIO-Europe 2008 To Get Biotech Industry Partnerships Started In Challenging Economic Environment 10/27/2008
    In order to seek out new partnering opportunities, the top 20 big pharma companies will be in attendance on November 17-19 in Mannheim/Heidelberg, Germany for BIO-Europe 2008, the world's largest stand-alone partnering conference.
  2. Guide To Successful Pharmabiotech Alliance Strategies: Providing A Comprehensive Analysis Of Driving Synergies, Avoiding Failure And Managing Relationships 10/24/2008
    Research and Markets http://www.researchandmarkets.com/research/3f2fff/successful_pharmab) has announced the addition of the "Successful Pharmabiotech Alliance Strategies: Driving Synergies, Avoiding Failure and Managing Relationships" report to their offering.
  3. Lupus Foundation Of America Awards More Than $1.1M In New Research Grants 10/23/2008
    The Lupus Foundation of America (LFA) has awarded more than $1.1 million in new research grants and fellowships as part of its ongoing commitment to bringing down the barriers in developing new treatments and finding a cure for lupus.
  4. Dalton Pharma Services And Myelin Repair Foundation Enter Into Chemistry Collaboration 10/22/2008
    The Myelin Repair Foundation and Dalton Pharma Services jointly announce a chemistry collaboration to develop new potential therapeutic compounds for myelin degradation disease states such as Multiple Sclerosis.
  5. Major Government Clinical Study Approved For Anadis' AIDS Therapy 10/21/2008
    Anadis Ltd. announced today that it has been informed by the Australian National Center in HIV Epidemiology and Clinical Research and the University of New South Wales
  6. Future Drug Pipelines And Prospects Revealed For RNAi Therapeutics 10/20/2008
    Research and Markets has announced the addition of the "The Future of RNAi Therapeutics: Drug Pipelines and Prospects" report to their offering.
  7. Despite Tight Financial Market, Company With Anti-Cancer Drug In Clinical Trial Raises $3.6M In Private Placement 10/20/2008
    During a time of tight credit, record-breaking stock market plunges, and shell-shocked investors, anti-cancer drug development firm Phoenix Biotechnology, Inc., has just completed a private placement in which the company raised $3.6 million from individual investors.
  8. Microfluidics Introduces New Services Designed To Enhance Customer Success 10/13/2008
    Microfluidics, announces the availability of several new services designed to enhance customer success and assist in customer innovation.
  9. CORRECTING And REPLACING Medidata Solutions Announces New Capabilities To Streamline Clinical Trial Start-Up And FDA Submissions 10/8/2008
    Second graph, second sentence of release should read: ...SDTM-compliant reports (sted: ...STDM-compliant reports).
  10. Stanford Scientists Pinpoint Key Proteins In Blood Stem Cell Replication 10/8/2008
    A family of cancer-fighting molecules helps blood stem cells in mice decide when and how to divide, say researchers at the Stanford University School of Medicine. Blocking the molecules’ function spurs the normally resting cells to begin proliferating strangely — making too much of one kind of cell and not enough of another